Foto på Pirjo Laakkonen

Pirjo Laakkonen

Professor

  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

1990 …2019
Om du gjort några ändringar i Pure kommer de visas här snart.

Publikationer 1990 2019

2019

Anagrelide for Gastrointestinal Stromal Tumor

Pulkka, O-P., Gebreyohannes, Y. K., Wozniak, A., Mpindi, J-P., Tynninen, O., Icay, K., Cervera, A., Keskitalo, S., Murumägi, A., Kulesskiy, E., Laaksonen, M., Wennerberg, K., Varjosalo, M., Laakkonen, P., Lehtonen, R., Hautaniemi, S., Kallioniemi, O., Schöffski, P., Sihto, H. & Joensuu, H., 1 mar 2019, I : Clinical Cancer Research. 25, 5, s. 1676-1687 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Octreotide Conjugates for Tumor Targeting and Imaging

Figueras, E., Martins, A., Borbely, A., Le Joncour, V., Cordella, P., Perego, R., Modena, D., Pagani, P., Esposito, S., Auciello, G., Frese, M., Gallinari, P., Laakkonen, P., Steinkuhler, C. & Sewald, N., maj 2019, I : Pharmaceutics. 11, 5, 14 s., 220.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Le Joncour, V., Karaman, S. & Laakkonen, P. M., 16 apr 2019, I : Journal of Visualized Experiments. 146, 12 s., 59384.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization

Le Joncour, V., Filppu, P., Hyvönen, M., Holopainen, M., Turunen, S. P., Sihto, H., Burghardt, I., Joensuu, H., Tynninen, O., Jääskeläinen, J., Weller, M., Lehti, K., Käkelä, R. & Laakkonen, P., jun 2019, I : EMBO molecular medicine. 11, 6, 21 s., 9034.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2018

Seek & Destroy, use of targeting peptides for cancer detection and drug delivery

Le Joncour, V. & Laakkonen, P., 1 jun 2018, I : Bioorganic & Medicinal Chemistry. 26, 10, s. 2797-2806 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Targeting peptides, a Swiss-army knife against cancer

Le Joncour, V. J. M. & Laakkonen, P., 2018, Amino Acids, Peptides and Proteins. Ryadnov, M. & Hudecz, F. (red.). Royal Society of Chemistry, Vol. 42. s. 281-320 40 s.

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

2017

Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness

Ylivinkka, I., Sihto, H., Tynninen, O., Hu, Y., Laakso, A., Kivisaari, R., Laakkonen, P., Keski-Oja, J. & Hyytiäinen, M., 9 jan 2017, I : Journal of Experimental and Clinical Cancer Research (Online). 36, 18 s., 9.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2016
Öppen tillgång
Fil

Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression

Eriksson, J., Le Joncour, V., Nummela, P., Jahkola, T., Virolainen, S., Laakkonen, P., Saksela, O. & Hölttä, E., 22 mar 2016, I : Oncotarget. 7, 12, s. 15065-15092 28 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells

Kaur, A., Denisova, O. V., Qiao, X., Jumppanen, M., Peuhu, E., Ahmed, S. U., Raheem, O., Haapasalo, H., Eriksson, J., Chalmers, A. J., Laakkonen, P. & Westermarck, J., 1 dec 2016, I : Cancer Research. 76, 23, s. 7001-7011 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2015

Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display

Hyvönen, M. & Laakkonen, P., 2015, CELL-PENETRATING PEPTIDES: METHODS AND PROTOCOLS. Langel, Ü. (red.). 2nd ed. red. Humana Press, s. 205-222 18 s. (Methods in molecular biology; vol. 1324).

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

Multifunctional porous silicon nanoparticles for cancer theranostics

Wang, C-F., Sarparanta, M. P., Mäkilä, E. M., Hyvönen, M. L. K., Laakkonen, P. M., Salonen, J. J., Hirvonen, J. T., Airaksinen, A. J. & Santos, H. A., apr 2015, I : Biomaterials. 48, s. 108-118 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2014

Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors

Hyvönen, M., Enback, J., Huhtala, T., Lammi, J., Sihto, H., Weisell, J., Joensuu, H., Rosenthal-Aizman, K., El-Andaloussi, S., Langel, U., Narvanen, A., Bergers, G. & Laakkonen, P., apr 2014, I : Molecular Cancer Therapeutics. 13, 4, s. 996-1007 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2013

Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas

Sarek, G., Ma, L., Enback, J., Järviluoma, A., Moreau, P., Haas, J., Gessain, A., Koskinen, P. J., Laakkonen, P. & Ojala, P. M., 28 feb 2013, I : Oncogene. 32, 9, s. 1091-1098 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Peptide-Based Glioma-Targeted Drug Delivery Vector gHoPe2

Eriste, E., Kurrikoff, K., Suhorutsenko, J., Osokolkov, N., Copolovici, D. M., Jones, S., Laakkonen, P., Howl, J. & Langel, U., mar 2013, I : Bioconjugate Chemistry. 24, 3, s. 305-313 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy

Kinnari, P. J., Hyvönen, M. L. K., Mäkilä, E. M., Kaasalainen, M. H., Rivinoja, A., Salonen, J. J., Hirvonen, J. T., Laakkonen, P. M. & Santos, H. A., dec 2013, I : Biomaterials. 34, 36, s. 9134–9141 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2012

An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis

Karhemo, P-R., Ravela, S., Laakso, M., Ritamo, I., Tatti, O., Mäkinen, S., Goodison, S., Stenman, U. H., Hölttä, E. J., Hautaniemi, S., Valmu, L., Lehti, K. I. & Laakkonen, P. M., 2012, I : Journal of Proteomics. 77, s. 87-100 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Metastasis-associated cell surface oncoproteomics

Karhemo, P-R., Hyvönen, M. & Laakkonen, P. M., 2012, I : Frontiers in Pharmacology. 3, 8 s., 192.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Tumour Targeting with Rationally Modified Cell-Penetrating Peptides

Mae, M., Rautsi, O., Enback, J., Hallbrink, M., Aizman, K. R., Lindgren, M., Laakkonen, P. & Langel, U., 1 dec 2012, I : International Journal of Peptide Research and Therapeutics. 18, 4, s. 361-371 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2011

An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer

Karhemo, P-R., Rivinoja, A., Lundin, J. E., Hyvönen, M., Chernenko, A., Lammi, J., Sihto, H., Lundin, M. E., Heikkilä, P., Joensuu, H., Bono, P. & Laakkonen, P. M., 2011, I : The American Journal of Pathology. 179, 2, s. 1004-1014 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Identification of homing peptides using the in vivo phage display technology

Rivinoja, A. & Laakkonen, P. M., 2011, I : Methods in molecular biology. 683, s. 401-415

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2010

Complex Formation Between Human Prostate-Specific Antigen and Protease Inhibitors in Mouse Plasma

Hekim, C., Riipi, T., Zhu, L., Laakkonen, P., Stenman, U. H. & Koistinen, H., 2010, I : Prostate. 70, 5, s. 482-490 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Homing peptides as targeted delivery vehicles

Laakkonen, P. & Vuorinen, K., 2010, I : Integrative Biology. 2, s. 326-337 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents

Peltonen, K., Colis, L., Liu, H., Jaamaa, S., Moore, H. M., Enback, J., Laakkonen, P., Vaahtokari, A., Jones, R. J., af Hallstrom, T. M. & Laiho, M., 2010, I : PLoS One. 5, 9, s. Article Number: e12996 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with In-111-labeled monoclonal antibodies

Huhtala, T., Laakkonen, P., Sallinen, H., Yla-Herttuala, S. & Narvanen, A., 2010, I : Nuclear Medicine and Biology. 37, s. 957-964 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Loss of Endothelial Tie1 Receptor Impairs Lymphatic Vessel Development-Brief Report

D Amico Lago, G. V., Korhonen, E. A., Waltari, M., Saharinen, P., Laakkonen, P. & Alitalo, K., 2010, I : Arteriosclerosis, Thrombosis, and Vascular Biology. 30, 2, s. 207-209 3 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2009

Antiangiogenic properties of prostate-specific antigen (PSA)

Mattsson, J. M., Laakkonen, P., Stenman, U-H. & Koistinen, H., 2009, I : Scandinavian Journal of Clinical & Laboratory Investigation. 69, 4, s. 447-451 5 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Identification of novel cancer-associated molecules

Chernenko, A., Reinman, M., Karhemo, P. R., Goodison, S., Takkinen, K. & Laakkonen, P., 2009, I : The FEBS Journal. 276, s. 106-106 1 s.

Forskningsoutput: TidskriftsbidragKonferensartikelVetenskapligPeer review

2008

A tumor homing peptide with potential as a pharmaceutical for cancer treatment and imaging

Laakkonen, P. M., Bergers, G. & Ruoslahti, E., 2008, Patentnr. 20085427

Forskningsoutput: PatentVetenskaplig

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation: [letters]

Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., Freitas, C., Duarte, A., Isoniemi, H., Laakkonen, P., Christofori, G., Ylä-Herttuala, S., Shibuya, M., Pytowski, B., Eichmann, A., Betsholtz, C. & 1 andraAlitalo, K., 2008, I : Nature. 31, 454(7204), s. 656-660 5 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Development of peptides specifically modulating the activity of KLK2 and KLK3

Koistinen, H., Närvänen, A., Pakkala, M., Helim, C., Mattsson, J., Zhu, L., Laakkonen, P. M. & Stenman, U-H., 2008, I : Biological Chemistry. 389, 6, s. 633-642 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Gene expression changes associated with the anti-angiogenic activity of kallikrein-related peptidase 3 (KLK3) on human umbilical vein endothelial cells

Mattsson, J., Laakkonen, P. M., Kilpinen, S., Stenman, U-H. & Koistinen, H., 2008, I : Biological Chemistry. 389, 6, s. 765-771 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Glycodelin reduces breast cancer xenograft growth in vivo

Hautala, L. C., Koistinen, R., Seppälä, M., Butzow, R., Stenman, U-H., Laakkonen, P. & Koistinen, H., 2008, I : International Journal of Cancer. 123, 10, s. 2279-2284 6 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Peptide targeting of tumor lymph vessels

Laakkonen, P., Zhang, L. & Ruoslahti, E., 2008, Annals of the New York Academy of Sciences: The Lymphatic Continuum Revisited. Wiley, Vol. 1131. s. 37-43 7 s.

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

Structural characterization and anti-angiogenic properties of prostate-specific antigen isoforms in seminal fluid

Mattsson, J., Valmu, L., Laakkonen, P. M., Stenman, U-H. & Koistinen, H., 2008, I : Prostate. 68, 9, s. 945-954 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Tumor targeting of baculovirus displaying a lymphatic homing peptide

Makela, A. R., Enback, J., Laakkonen, J. P., Vihinen-Ranta, M., Laakkonen, P. & Oker-Blom, C., 2008, I : Journal of Gene Medicine. 10, s. 1019-1031 13 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors: [correspondence]

Petrova, T., Bono, P., Holnthoner, W., Chesnes, J., Pytowski, B., Sihto, H., Laakkonen, P., Heikkilä, P., Joensuu, H. & Alitalo, K., 2008, I : Cancer Cell. 13, 6, s. 554-556 3 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2007

A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta 24, for the treatment of advanced breast cancer

Ranki, T., Kanerva, A., Ristimaki, A., Hakkarainen, T., Sarkioja, M., Kangasniemi, L., Raki, M., Laakkonen, P., Goodison, S. & Hemminki, A., 2007, I : Gene Therapy (Basingstoke). 14, s. 58-67 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

p53-kasvurajoitereitin aktivaatio - uusi mahdollisuus virusperäisen lymfooman hoitoon: [J Clin Invest in press]

Sarek, G., Kurki, S., Enbäck, J., Iotzova, G., Haas, J., Laakkonen, P. M., Laiho, M. & Ojala, P. M., 2007, I : Duodecim. 123, 8, s. 869-870 2 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskaplig

Peptides that home to tumor lymphatic vasculature and methods of using same

Laakkonen, P. M., Porkka, K., Hoffman, J. A. & Ruoslahti, E., 2007, Patentnr. 7671021

Forskningsoutput: PatentVetenskaplig

Proteomic profiling of invasive cancer cells reveals a novel prognostic marker for human breast cancer

Karhemo, P. R., Syrjakari, H., Kivinen, P., Valmu, L., Lundin, J., Joensuu, H., Laiho, M., Bono, P. & Laakkonen, P., 2007, I : EJC supplements. 5, s. 60-60 1 s.

Forskningsoutput: TidskriftsbidragKonferensartikelVetenskaplig

Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas

Sarek, G., Kurki, S., Enbäck, J., Iotzova, G., Haas, J., Laakkonen, P. M., Laiho, M. & Ojala, P., 2007, I : Journal of Clinical Investigation. 117, 4, s. 1019-1028 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Tumour-homing peptides: tools for targeting, imaging and destruction

Enback, J. & Laakkonen, P., 2007, I : Biochemical Society Transactions. 35, s. 780-783 4 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth

Laakkonen, P., Waltari, M., Holopainen, T., Takahashi, T., Pytowski, B., Steiner, P., Hicklin, D., Persaud, K., Tonra, J. R., Witte, L. & Alitalo, K., 2007, I : Cancer Research. 67, 2, s. 593-599 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2006

Characterization of the Rab8-specific membrane traffic route linked to protrusion formation

Hattula, K., Furuhjelm, J., Tikkanen, J., Tanhuanpää, K., Laakkonen, P. M. & Peränen, J., 2006, I : Journal of Cell Science. 119, s. 4866-4877 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Targeting tie-1 inhibits the growth of tumor xenografts as a monotherapy and has increased activity in combination with a VEGF inhibitor

Dransfield, D., Laakkonen, P., Jussila, M., Arulanandam, A., Huang, L., Devy, L., Chen, J., Chang, Q., Pazmany, C., Rookey, K., Viswanathan, M., Mullberg, J., Schaus, J., Schoonbroodt, S., Steukers, M., Ladner, R., Wood, C. & Alitalo, K., 2006, I : EJC supplements. 4, s. 34-34 1 s.

Forskningsoutput: TidskriftsbidragKonferensartikelVetenskaplig

Tie Receptor And Tie Ligand Materials And Methods For Modulating Female Fertility

Alitalo, K., Laakkonen, P. M., Kubo, H. & Sainio, K., 2006, Patentnr. 2006002854

Forskningsoutput: PatentVetenskaplig

2005

Identification of breast cancer metastasis and chronic myeloid leukemia-specific cell surface proteins

Karhemo, P., Goodison, S., Porkka, K. & Laakkonen, P., 2005, I : Molecular & Cellular Proteomics. 4, 8 Suppl. 1, s. S114-S114 1 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Multivalent antibody materials and methods for VEGF/PDGF family of growth factors

Alitalo, K., Eriksson, U., Achen, M., Cregory Renner, C., Stacker, S., Li, H. & Laakkonen, P. M., 2005, Patentnr. 2005087812

Forskningsoutput: PatentVetenskaplig